ANGPT1 and cardiac hypertrophy: Administration or targeted overexpression of Ang-(1–7) in the heart prevented cardiac hypertrophy and fibrosis induced by Ang II [40], [43], which were mediated by Ang-(1–7) mas receptor [42], [77].